Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts
This study has been completed.
Study NCT00142779   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 1, 2005   Last Updated: May 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine-Related Disorders
Opioid-Related Disorders
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Pathologic Processes
Substance-Related Disorders
Interventions listed in this trial
Fluoxetine
Additional drug interventions recognized in this trial
Cocaine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Antidepressive Agents
Antidepressive Agents, Second-Generation
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services